Reader Remarks on:

The HORIZON Study: Bisphosphonates for Patients on Corticosteroids

how about pediatric patients
pediatric patients

how about pediatric patients

TL Lee, 11 May 2009 1:52 PM EST

Competing interests: None declared

what is your recommendation in pediatrics patients receiving high dose corticosteroid?

pediatric patients

Jeffrey Callen, University of Louisville; Deputy and Feature Editor, Journal Watch Dermatology, 13 May 2009 2:41 PM EST

Competing interests: None declared

Bone loss is a potential problem for these patients as well, but even more of an issue is the stunting of growth. The bisphosphonates are not approved for use in children, therefore you should discuss their use carefully with the patient's primary provider and assess the risks before prescribing.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests:

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Sign-In

Forgot your password?

New to Journal Watch?